The best partner
for advanced clinical research

Solid experience in rare diseases, orphan drugs, first in human and advanced therapies.

Widespread knowledge of the Italian regulatory framework.

Solid experience in rare diseases, orphan drugs, first in human and advanced therapies.

Widespread knowledge of the Italian regulatory framework.

Agile hierarchical structure and flexible decision making.

Entirely owned by a pool of professionals in clinical research.

Solid and established partnership for international clinical trials.

Hippocrates Research (HR) is the company of Hippocrates Group qualified as a CRO (Contract Research Organization).

Team

90% women, 93% graduates, employee turnover ¼ Italian industry and trained staff by external Managers

Regulatory qualifications

Qualified by: AIFA, EMA, EudraVigilance, and ENCePP

Features

Digital clinical trials (inc. e-CRF, e-TMF and e-PRO), Remote monitoring, Phase I units accreditation and Full statistical services

Quality

ISO 9001:2015 certified, SIMeF – GIQAR affiliates, GDPR compliant (independent DPO) and Global Compact Member

Finance

Debt free Company, Private owned company and Customer retention rate 84% in value

About us

Our core business

We aim to be the best-in-class full-service CRO worldwide, specialized in clinical research.

HR serves customers in Europe (52%), North America (19%) Japan (9%) and Italy (20%). About 80% of the HR’s annual revenues come from services related to clinical research, including regulatory consultancy, conducted for non-Italian customers. The total number of customers has more than doubled in the last 5 years and foreign customers have more than quadrupled in the same period. Customer retention rate (2020) was 71% in number of contracts and 84% in value. HR supports studies in Italy, from first-in-human to phase 4 (around 50% of total revenues).

More than 40% of the total turnover is given by NIS, including PASS and over 10% by medical devices and food supplements. With 3.000+ clinical sites activated in Italy in various therapeutical areas, HR has recognized cutting-edge expertise for studies in Cardiology, Onco-haematology, Gastroenterology, Dermatology, Urology, Sexual Health, Neurology, Psychiatry and Infectiology. HR’s expertise is also recognized in Rare Diseases, Paediatrics and Ophthalmology.

Interventional PHASE I/IV

NISS/PASS

MD

Nutraceutical

Our Services

Original features and innovation

Digital clinical interventional trials on-going with >70% reduction of study visits with physical interaction doctor-patient and >90% of the data efficacy generated and collected remotely.

Remote monitoring equipment and know-how to perform up to 90% remote SDV of documents at the site.

A broad domestic network of GPs and paediatricians, GCP trained, suitable to carry out interventional phase III-IV and NIS and food supplement trials. Partnership with Italian Universities in place supporting pre-clinical research activities in gastro-enterology and dermatology.

Therapeutic Areas